Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravirNatco has conducted Phase III trials of molnupiravir and submitted the trial results to the drug regulator this month. "We have submitted p...
28 Oct, 2021, 11.29 PM IST
Eli Lilly buckles under pressure, offers voluntary licence to Natco PharmaLily has issued voluntary licenses for Barcitinib to six Indian drug makers besides Natco, these include- Sun Pharma, Cipla, Dr Reddy's, Lu...
17 May, 2021, 12.33 PM IST
NPPA lens on five pharma companies for Hepatitis C drug overchargeNPPA has sent show-cause notices to these companies alleging overcharging for the combination drug used to treat the potentially fatal Hepa...
09 Jan, 2018, 10.38 AM IST
Patent not to affect hepatitis C drug price in India: Gilead Sciences Inc"It is the company's goal to enable access to these medicines for as many people as possible, as quickly as possible," the spokesperson add...
11 May, 2016, 10.57 PM IST
Cipla, Emcure, Hetero and Natco Pharma join patent pool for new Hepatitis C drug DaclatavirThere might be more companies who might join the patent pool for the drug. Daclatasvir is known to cure multiple genotypes of the Hep C vir...
20 Jan, 2016, 05.20 PM IST
Pharma companies blame archaic law for lack of swine flu drugs"Since the drug comes under Schedule X, there are various licences required to stock the medicines, which dissuades chemists to stock them,...
19 Feb, 2015, 05.55 AM IST
Cipla may cut prices of other cancer drugs tooCipla may extend its “affordable and humanitarian” pricing strategy on other anti-cancer drugs in its portfolio, even as domestic cos strug...
05 May, 2012, 05.50 AM IST
- Complete formalities on Novartis patent claim: SC
The Supreme Court on Friday directed the Centre, Cipla, Ranbaxy, Hetero Drugs, Natco Pharma and others to complete their pleadings in the m...
03 Dec, 2010, 07.39 PM IST
- Govt may cap retail price of swine flu drug
The government may cap the retail price of anti-viral drug oseltamivir used for the treatment of swine flu if market competition does not f...
15 Oct, 2009, 04.00 AM IST
- Natco in talks with pharma retail chains
Hyderabad-based drug company Natco Pharma, which launched its anti-HINI drug 'Natflu' in the national capital, said it is talking with vari...
25 Sep, 2009, 06.12 PM IST
- Natco in race for govt deal
Natco is in race to bag a government contract for supply of 10 million Tamiflu, used to treat swine flu.
23 Sep, 2009, 01.22 AM IST
- Natco aims to sell 10 m flu capsules
Hyderabad-based Natco Pharma expects to sell 10 million capsules of Natflu, the generic version of Tamiflu-Oseltamivir, used to treat swine...
23 Sep, 2009, 01.21 AM IST
- Hetero bags deal for 10 m Tamiflu
Hetero Drugs has pipped Ranbaxy Laboratories, Cipla, Natco Pharma, Strides Arcolabs and Roche India to bag half the government order to sup...
22 Aug, 2009, 03.02 AM IST
- Cipla, Ranbaxy in fray to bag govt contract for Tamiflu
Drugmakers Cipla, Ranbaxy, Hetero and Natco are expected to be in the fray to bag the government's contract to buy 20 million low cost anti...
11 Aug, 2009, 12.05 PM IST
- Govt gets into the act to combat flu
The health ministry is now building a bank of 6 million tablets of anti-viral tablets besides maintaining a stockpile of 10 million tablets.
05 Aug, 2009, 12.30 AM IST
- Hetero bags mega chunk of govt's anti-flu drug deal
Hyderabad-based Hetero Drugs has bagged the lion’s share of the government’s 10-million anti-flu drug order.
05 May, 2009, 12.03 AM IST
- Hetero Drugs close to receiving orders for its swine flu medicines
Hyderabad-based Hetero Drugs is close to receiving orders from foreign countries for its swine flu medicines worth at least $10 mn in the n...
04 May, 2009, 06.38 PM IST